SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neopath (NPTH)
NPTH 0.0006000.0%Mar 7 3:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Karl who wrote (63)11/25/1997 11:55:00 PM
From: Sigmund  Read Replies (1) of 178
 
It's been frustrating watching the price of NeoPath decline even though regulatory approval would appear to be probable in the relatively short term. Does somebody know something bad about the prospects? But when I look at some other stocks in the sector, CYTEC, Neuromedical, and Matritech, I see that it is a sector trend and in fact NeoPath is holding its value better than these other companies. Perhaps this is a positive sign.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News